209 Items, 11 Pages <<Prev 1 2 3 4 5 6 7 8 9 10 Next>> All
| No. | Name of Lifestyle | Third Class | Second Class | First Class | Type | No. of Studies |
|---|---|---|---|---|---|---|
| 1 | # of different types of STIs | STD | Diseases | Clinical characteristics | Risk factor No statistical significance factor | 1 |
| 2 | 1-stearoylglycerol | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 3 | 1-stearoylglycerol,1-monostearin | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 4 | 10-heptadecenoate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 5 | 10-nonadecenoate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 6 | 21-hydroxypregnenolone disulfate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 7 | 2arachidonoylglycerophosphoethanolamine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 8 | 3-hydroxyisobutyrate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 9 | 3-methyl-2-oxobutyrate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 10 | 5-dodecenoate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 11 | 5-methylthioadenosine | Metabolic factors | Biochemical examination | Clinical characteristics | Risk factor | 1 |
| 12 | Acetaminophen | Analgesic and anti-inflammatory drugs | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 13 | Acne | Acne | Diseases | Clinical characteristics | No statistical significance factor | 1 |
| 14 | Age at circumcision | Circumcision | Surgery | Clinical characteristics | Protective factor No statistical significance factor | 1 |
| 15 | Age at diabetes diagnosis | Diabetes | Diseases | Clinical characteristics | Protective factor No statistical significance factor | 1 |
| 16 | Age at first of Anticoagulants | Anticoagulants | Drug | Clinical characteristics | No statistical significance factor | 1 |
| 17 | Alanine | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 18 | Allergen-specific IgE | IgE | Diseases | Clinical characteristics | Reference | 1 |
| 19 | alpha-ketoglutarate | Metabolic factors | Biochemical examination | Clinical characteristics | Protective factor | 1 |
| 20 | Antidiabetic drug | Antidiabetic | Drug | Clinical characteristics | Protective factor Risk factor No statistical significance factor | 1 |